Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
NHS Strikes New Covid Surge Deal With Independent Sector
Local hospitals will be able to quickly activate surge capacity in the independent sector as […]
NHS Strikes Deal to Make PKU Drug Available For All
The NHS is set to make a drug for the rare, debilitating disorder phenylketonuria (PKU) […]
NHS to Offer Booster Booking to Every Adult by End of December
The NHS vaccination programme will offer every adult the chance to book a covid-19 booster […]
UK's Most Vulnerable People to Receive Life-saving COVID-19 Treatments in the Community
Thousands of the UK’s most vulnerable people will be among the first in the world to […]
Total NHS Covid Vaccines Top 96 Million, Amid Concern Over New Variant
Total Covid vaccinations in England have hit the 96 million mark as the NHS Covid-19 […]
More People With Diabetes Set to Benefit From Blood Sugar Monitors as NHS Roll-Out Succeeds
Half of NHS Type 1 diabetes patients in England are now benefiting from the use […]
Top Up Jab Bookings to Open Up For More Than One Million People
More than one million people will be eligible to book their life-saving jab top-up from […]
NHS Deal On Spinal Muscular Atrophy (SMA) First Home Treatment
A life-changing drug that can improve mobility in children and adults with a rare genetic […]
Thousands Spared Strokes Thanks to New NHS Drug Agreements
More than 20,000 strokes and 5,000 deaths could be averted after NHS England struck new […]
Whole Genome Sequencing Improves Diagnosis of Rare Diseases and Shortens Diagnostic Journeys for Patients, According to World First Study
A world-first scientific study, published today in the New England Journal of Medicine, has shown that […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more